Dual Antiplatelet Therapy: Balancing Ischemic and Bleeding Risk

episode

JAMA Clinical Reviews not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 7PM EDT 4 min · 22 Sep 2026 · NPR News Now

Garry and Tim - Full Show - Wednesday September 23 (23.09.26) 1h 53m · 22 Sep 2026 · SEN Breakfast

H4 N2K, Shehan Jeyarajah, The Kicker 45 min · 22 Sep 2026 · The Program

US-Iran Talks on Sidelines of UN Summit, Chipmakers Rally, More 7 min · 22 Sep 2026 · Bloomberg News Now

7PM ET 09/22/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Dentists Are Making Millions From This Lie - Dr. Ellie Phillips EXPOSES the dental industry 1h 5m · 22 Sep 2026 · Redacted News

Report any issue

Source

Recorded11 Jul 2017

Publisherjamaclinicalreviews.libsyn.com ↗

Handlerec:7722891

Show notes

Following placement of cardiac stents, patients receive dual antiplatelet therapy (DAPT) to prevent stent thrombosis. Prevention of thrombosis is offset by a risk of bleeding. The optimal balance between thrombosis prevention and bleeding risk is not always known. How to go about optimizing DAPT therapy is discussed by Glen Levine, MD, professor of medicine at Baylor College of Medicine in Houston, Texas, and chair of the combined American College of Cardiology/American Heart Association Guideline Committees.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in